SCHEMBL7433502

SCHEMBL7433502

CC(C)[C@H](N)C(=O)N(C(=O)CCc1ccccn1)[C@@H](Cc1ccccc1)C(F)(F)[C@H](O)[C@H](Cc1ccccc1)N(C(=O)CCc1ccccn1)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
CA2 P00918 2/20 0.35
RAF1 P04049 1/20 0.34
MAP2K1 Q02750 1/20 0.34
KMT2A Q03164 1/20 0.33
PTPRA P18433 1/20 0.33
MAOB P27338 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
HTT P42858 2/20 0.32
HTR5A P47898 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269409 0.87 CYP1A2 (0.45) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL6449597 0.86 CYP1A2 (0.44) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7268623 0.84 PGR (0.40) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7334043 0.83 CYP1A2 (0.39) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7278045 0.78 PGR (0.41) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL8536296 0.78 PGR (0.36) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7338424 0.77 CYP1A2 (0.38) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7270433 0.72 TSHR (0.56) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7269049 0.72 LMNA (0.47) CYP1A2MAPT
SCHEMBL6447519 0.71 LMNA (0.48) CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed